Harald Holte

Oslo University Hospital — Norway

Medicine · Health Sciences

58h-index27.6kcitations440works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(291), CAR-T cell therapy research(80), Chronic Lymphocytic Leukemia Research(73), Viral-associated cancers and disorders(53), CNS Lymphoma Diagnosis and Treatment(47)

Publications439 total

Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma
Journal of Clinical Oncology·2025· 3 citedOpen Access
Molecular Surveillance of Aggressive Large B-cell Lymphoma using Circulating Tumor DNA Duplexes
2025Open Access
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Blood·2025· 5 citedOpen Access
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Blood Advances·2025· 7 citedOpen Access
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma
American Journal of Hematology·2025· 3 citedOpen Access
153 | HARNESSING SYSTEMIC INFLAMMATION WITH CIRCULATING TUMOR DNA IMPROVES SURVIVAL PREDICTION IN LARGE B‐CELL LYMPHOMA
Hematological Oncology·2025Open Access
Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma
HemaSphere·2025· 5 citedOpen Access
Abstract 1942: Copy number aberrations in the ctDNA uncover clinical and biological heterogeneity in aggressive B-cell lymphomas
Cancer Research·2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
2025Open Access
Allogeneic stem cell transplantation for patients with lymphoma 2011–21
Tidsskrift for Den norske legeforening·2025· 1 citedOpen Access
Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus–seronegative kidney transplant recipients — an observational cohort study from Norway and western Denmark
American Journal of Transplantation·2025· 5 citedOpen Access
Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas
Haematologica·2024· 6 citedOpen Access
Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and <i>MYC</i> Rearrangement- an L.L.M.P.P. Study
Blood·2024· 2 cited
Clonal Hematopoiesis Mutations and Cell-Free DNA Characteristics in Patients with High-Risk Large B-Cell Lymphomas
Blood·2024Open Access
Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial
Blood·2024· 8 citedOpen Access
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
Blood Cancer Journal·2024· 8 citedOpen Access
MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration
Patterns·2024· 2 citedOpen Access
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Med·2024· 5 citedOpen Access
Inflammatory and Subtype Dependent Serum Protein Signatures Predict Survival Beyond the ctDNA in Aggressive B-Cell Lymphomas
SSRN Electronic Journal·2024Open Access
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Blood Advances·2023· 24 citedOpen Access
page 1 of 22Next →

Frequent Co-authors

Jan Delabie(18), Erlend B. Smeland(15), Stein Kvaløy(14), Randy D. Gascoyne(13), Andreas Rosenwald(11), Elı́as Campo(11), Elaine S. Jaffe(11), Wing C. Chan(10), Joseph M. Connors(10), Dennis D. Weisenburger(10), Jamés O. Armitage(10), German Ott(10), Louis M. Staudt(10), George W. Wright(9), Richard I. Fisher(8), Timothy C. Greiner(8), Julie M. Vose(8), Wyndham H. Wilson(7), Thomas P. Miller(7), Lisa M. Rimsza(7)